X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: What is the Extra Help program?

By Nicole Longo  |    August 21, 2017
Medicare Part D’s Extra Help program helps low-income beneficiaries better afford their medicines. In fact, millions of beneficiaries have received Extra Help in Part D.   Read More

Medicare Monday: Strengthening access to vaccines for seniors

By Nicole Longo  |    August 14, 2017
This month, we’re celebrating National Immunization Awareness Month! Although children may come to mind first when we think of vaccination, access to immunization is just as important for older...   Read More

Medicare Monday: Part D premiums expected to drop in 2018

By Nicole Longo  |    August 7, 2017
Great news for seniors and people living with disabilities who rely on Part D! Last week, the Centers for Medicare & Medicaid Services (CMS) announced that Medicare Part D prescription drug plan...   Read More

ICYMI: New report outlines steps for greater transparency in health care

By Katie Koziara  |    August 4, 2017
Last week, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater transparency in health care. The report states that helping consumers make...   Read More

PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis

By Anne McDonald Pritchett, PhD  |    August 2, 2017
Just about every day, I read a news story about the opioid crisis or talk to someone who has been personally impacted by addiction. According to the CDC, opioids, including prescription opioids...   Read More

Medicare Monday: Medicare turns 52!

By Nicole Longo  |    July 31, 2017
This weekend (July 30) marked 52 years since Medicare was signed into law by President Lyndon B. Johnson as a part of the Social Security Act Amendments. To celebrate the occasion, we are taking a...   Read More

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

By Holly Campbell  |    July 31, 2017
PhRMA president and CEO Stephen J. Ubl joined Squawk Box this morning to put medicine costs and spending in context, the biopharmaceutical supply chain and policy solutions to address cost...   Read More

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

By Andrew Powaleny  |    July 31, 2017
The Bay Area in California has long been considered a nucleus of innovation, having produced groundbreaking inventions and discoveries over the last few decades – spanning nearly every industry,...   Read More

Biopharmaceutical industry policies aim to increase access to clinical trial data

By Olivia Shopshear  |    July 27, 2017
Today, a study published in the British Medical Journal (BMJ) sought to audit industry clinical trial disclosure and data sharing policies. The study, entitled Pharmaceutical companies’ policies...   Read More

Opportunities to build upon enhanced competition for medicines in the marketplace

By David Korn  |    July 27, 2017
Last week, I presented at the U.S Food and Drug Administration’s (FDA) public meeting on the Hatch-Waxman Amendments to discuss the balance between encouraging innovation in biopharmaceutical...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates